Recursion Pharmaceuticals, Inc. (RXRX)

Healthcare · Biotechnology · NASDAQ

Recursion Pharmaceuticals, Inc. (RXRX) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $1.73B and a free-cash-flow yield of -26.4%. Over the most recent reported fiscal year, revenue grew 27.0%.

Market cap	$1.73B
Trailing P/E	—
FCF yield	-26.4%
Revenue growth (YoY)	+27.0%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live RXRX data on Nama Insights →